VBI Vaccines(VBIV) - 2023 Q4 - Annual Report
VBI VaccinesVBI Vaccines(US:VBIV)2024-04-16 12:01

● imposition of a clinical hold following an inspection of our clinical trial operations or trial sites by the FDA or other regulatory authorities; ● delays in identifying, recruiting, and training suitable clinical investigators; ● time required to add new sites; Patient enrollment, a significant factor in the timing of clinical trials, is affected by many factors, including the size and nature of the patient population, the proximity of patients to clinical sites, the eligibility criteria for the trial, t ...